P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial
Titel:
P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial
Auteur:
Focan, C. Beauduin, M. Salamon, E. de Greve, J. de Wasch, G. Lobelle, J.P. Majois, F. Tagnon, A. Tytgat, J. Van Belle, S. Vandervellen, R. Vindevoghel, A.